MARK G EDWARDS Insider Trading $ACRX ACELRX PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARK G EDWARDS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARK G EDWARDS. MARK G EDWARDS is Director in ALLOS THERAPEUTICS INC ($ALTH) and Director in ACELRX PHARMACEUTICALS INC ($ACRX).
MARK G EDWARDS in ACELRX PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARK G EDWARDS: Director
Holdings: 251,250 shares
Current Value: $753,750
Latest Transaction: Jun 16 2020
$ACRX Market Capitalization: $131.47M
$ACRX Previous Close: $3.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARK G EDWARDS in ACELRX PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2020 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Option Exercise | A | 1.43 | 15,000 | 21,450 | 15,000 | |
| Jun 16 2020 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Grant | A | 0.00 | 7,500 | 0 | 251,250 | 243.8 K to 251.3 K (+3.08 %) |
| Nov 12 2019 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 1.78 | 25,000 | 44,575 | 243,750 | 218.8 K to 243.8 K (+11.43 %) |
| Aug 26 2019 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 2.17 | 5,000 | 10,850 | 218,750 | 213.8 K to 218.8 K (+2.34 %) |
| Aug 26 2019 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 2.20 | 10,000 | 21,956 | 213,750 | 203.8 K to 213.8 K (+4.91 %) |
| Jun 25 2019 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Option Exercise | A | 2.19 | 7,500 | 16,425 | 7,500 | |
| Jun 25 2019 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Grant | A | 0.00 | 3,750 | 0 | 203,750 | 200 K to 203.8 K (+1.88 %) |
| Mar 12 2019 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 2.99 | 19,000 | 56,890 | 200,000 | 181 K to 200 K (+10.50 %) |
| Nov 15 2018 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 2.82 | 20,700 | 58,376 | 181,000 | 160.3 K to 181 K (+12.91 %) |
| Aug 08 2018 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 2.84 | 5,300 | 15,063 | 160,300 | 155 K to 160.3 K (+3.42 %) |
| Aug 08 2018 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 2.84 | 5,300 | 15,063 | 160,300 | 155 K to 160.3 K (+3.42 %) |
| Jun 14 2018 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Option Exercise | A | 4.13 | 15,000 | 61,875 | 15,000 | |
| Jun 05 2018 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 3.35 | 4,700 | 15,745 | 155,000 | 150.3 K to 155 K (+3.13 %) |
| Jun 05 2018 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 3.30 | 300 | 990 | 150,300 | 150 K to 150.3 K (+0.20 %) |
| Nov 15 2017 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 1.90 | 30,000 | 56,970 | 150,000 | 120 K to 150 K (+25.00 %) |
| Aug 24 2017 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 3.03 | 4,800 | 14,520 | 120,000 | 115.2 K to 120 K (+4.17 %) |
| Aug 24 2017 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 2.90 | 200 | 580 | 115,200 | 115 K to 115.2 K (+0.17 %) |
| Jun 15 2017 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Option Exercise | A | 2.30 | 15,000 | 34,500 | 15,000 | |
| Jun 22 2016 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Option Exercise | A | 2.87 | 15,000 | 43,050 | 15,000 | |
| May 12 2016 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 3.05 | 5,000 | 15,250 | 115,000 | 110 K to 115 K (+4.55 %) |
| May 12 2016 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 3.15 | 5,000 | 15,750 | 110,000 | 105 K to 110 K (+4.76 %) |
| May 12 2016 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 3.25 | 5,000 | 16,250 | 105,000 | 100 K to 105 K (+5.00 %) |
| Jun 24 2015 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Option Exercise | A | 4.08 | 15,000 | 61,200 | 15,000 | |
| May 07 2015 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Buy | P | 3.13 | 40,000 | 125,116 | 100,000 | 60 K to 100 K (+66.67 %) |
Page: 1